TY - JOUR
T1 - Resting-state dynamics as a neuromarker of dopamine administration in healthy female adults
AU - Bellucci, Gabriele
AU - Münte, Thomas F.
AU - Park, Soyoung Q.
N1 - Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: This work was supported by Deutsche Forschungsgemeinschaft grants INST 392/125-1 (SFB-TRR 134, C07) and PA 2682/1-1 (to S.Q.P.), as well as SFB-TRR 134, C01 (to T.F.M.).
Publisher Copyright:
© The Author(s) 2019.
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2019/8/1
Y1 - 2019/8/1
N2 - Background: Different neuromarkers of people’s emotions, personality traits and behavioural performance have recently been identified. However, not much attention has been devoted to neuromarkers of neural responsiveness to drug administration. Aims: We investigated the predictive neuromarkers of acute dopamine (DA) administration. Methods: In a double-blind, within-subject study, we administrated a DA agonist (pramipexole) or placebo to 27 healthy female subjects. Using multivariate classification and prediction analyses, we examined whether dopaminergic modulations of task-free resting-state brain dynamics predict individual differences in pramipexole’s modulation of facial attractiveness evaluations. Results: Our results demonstrate that pramipexole’s effects on brain dynamics could be successfully discriminated from resting-state functional connectivity (accuracy: 78.9%; p < 0.0001). On the behavioural level, pramipexole increased facial attractiveness evaluations (t(39) = 4.44; p < 0.0001). In particular, pramipexole administration enhanced connectivity strength of the cinguloopercular network (t(23) = 3.29; p = 0.003) and increased brain signal variability in subcortical and prefrontal brain areas (t(13) = 3.05, p = 0.009). Importantly, multivariate predictive models reveal that pramipexole-dependent modulation of resting-state dynamics predicted the increase of facial attractiveness evaluations after pramipexole (connectivity strength: standardized mean squared error, smse = 0.65; p = 0.0007; brain signal variability: smse = 0.94, p = 0.015). Conclusion: These results demonstrate that modulations of resting-state brain dynamics induced by a DA agonist predict drug-related effects on evaluation processes, providing a neuromarker of the neural responsiveness of specific brain networks to DA administration.
AB - Background: Different neuromarkers of people’s emotions, personality traits and behavioural performance have recently been identified. However, not much attention has been devoted to neuromarkers of neural responsiveness to drug administration. Aims: We investigated the predictive neuromarkers of acute dopamine (DA) administration. Methods: In a double-blind, within-subject study, we administrated a DA agonist (pramipexole) or placebo to 27 healthy female subjects. Using multivariate classification and prediction analyses, we examined whether dopaminergic modulations of task-free resting-state brain dynamics predict individual differences in pramipexole’s modulation of facial attractiveness evaluations. Results: Our results demonstrate that pramipexole’s effects on brain dynamics could be successfully discriminated from resting-state functional connectivity (accuracy: 78.9%; p < 0.0001). On the behavioural level, pramipexole increased facial attractiveness evaluations (t(39) = 4.44; p < 0.0001). In particular, pramipexole administration enhanced connectivity strength of the cinguloopercular network (t(23) = 3.29; p = 0.003) and increased brain signal variability in subcortical and prefrontal brain areas (t(13) = 3.05, p = 0.009). Importantly, multivariate predictive models reveal that pramipexole-dependent modulation of resting-state dynamics predicted the increase of facial attractiveness evaluations after pramipexole (connectivity strength: standardized mean squared error, smse = 0.65; p = 0.0007; brain signal variability: smse = 0.94, p = 0.015). Conclusion: These results demonstrate that modulations of resting-state brain dynamics induced by a DA agonist predict drug-related effects on evaluation processes, providing a neuromarker of the neural responsiveness of specific brain networks to DA administration.
UR - http://www.scopus.com/inward/record.url?scp=85068350911&partnerID=8YFLogxK
U2 - 10.1177/0269881119855983
DO - 10.1177/0269881119855983
M3 - Journal articles
C2 - 31246145
AN - SCOPUS:85068350911
SN - 0269-8811
VL - 33
SP - 955
EP - 964
JO - Journal of Psychopharmacology
JF - Journal of Psychopharmacology
IS - 8
ER -